Patients (pts) with stage IV, non-metastatic advanced head and neck squamous cell carcinoma (HNSCC) submitted to concurrent chemoradiotherapy (CCR) present with manageable toxicity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results